All research studies at Lurie Children’s involving human participants require prior approval from the Institutional Review Board (IRB). Lurie Children’s two IRBs, Panel #1 and Panel #2, are composed of a diverse selection of experts in the field of pediatric research.
Both IRBs are organized and operate in compliance with the Department of Health and Human Services (DHHS) regulations, as described in 45 CFR 46, for federally funded research and FDA regulations, as described in 21 CFR Parts 50 and 56, for FDA regulated research. In addition, the IRBs operate in compliance with portions of the HIPAA Privacy Rule that apply to research, as described in 45 CFR Parts 160 and 164.
For a copy of the Federalwide Assurance (FWA)/IRB Registration (IORG)/IRB Roster, please click here.
IRB Meeting Dates and Submission Deadlines
IRB Panel #1 and Panel #2 Deadlines & Meeting Dates for 2022.
Policies & Guidelines
Please navigate to the following pages for all policies, procedures, and guidance for conducting research with human participants and obtaining and maintaining IRB approval at Lurie Children’s.
For studies that involve Lurie Children’s and Northwestern University, a Master IRB Authorization Agreement is in place for Lurie Children’s to serve as the IRB of record. Please refer to instructions on how to submit these studies.